The Horizons Tracker

JUNE 9, 2021

The authors argue that it isn’t necessary for the public to understand how AI works in order for them to trust it, but they do need to know that someone with the knowledge to examine and understand how it’s operating has the authority to oversee it and sanction its developers if it begins to cause harm. ” Playing a part.

Document 78

Document Pharmaceuticals Discount Technology 78

The Horizons Tracker

SEPTEMBER 10, 2021

By contrast, firms operating in areas such as online retail, pharmaceuticals, and information and communications technology, have all thrived. The researchers highlight the particular impact on businesses in the travel and hospitality sectors, who have all suffered due to the lockdown measures. Face-to-face interactions.

Pharmaceuticals 68

Pharmaceuticals Transportation Retail Long-term 68

Strategy Driven

DECEMBER 18, 2020

Gayhardt states that Hong Kong is already increasing its use of advanced fraud detection, biometric facial recognition, and other innovative AI technologies due to the pandemic. Clothing retailers, restaurants and grocery stores, and even some pharmaceutical products have all seen delays in 2020 as well.

Supply Chain 85

Supply Chain Retail Pharmaceuticals Technology 85

The Horizons Tracker

NOVEMBER 29, 2023

According to a study conducted by the Indiana University Kelley School of Business, diversity in terms of gender, race, and ethnicity has proven to be beneficial for companies operating in the United States. “We looked at their experiences and not just their demographic background—the more functional aspect of diversity. ” .

Diversity 101

Diversity Innovation Biotechnology Short-term 101

The Horizons Tracker

OCTOBER 9, 2019

One of the more interesting projects in this field is undertaken by pharmaceutical giant GSK, who offer their GSK Science in the Summer program to 2nd-6th graders to help engage them in STEM-related topics. The program operates from 27 locations across the United States, including New Mexico, Maine, Montana and Louisiana.

Pharmaceuticals 67

Pharmaceuticals Education ROI Project 67

Marshall Goldsmith

FEBRUARY 8, 2018

Co-founder of Rose Park Advisors—Disruptive Innovation Fund. A leading thinker on strategy and breakthrough innovation. a holding company that operates seven distinct business. Operations Group Baring Private Equity. Formerly a leader in the automotive, retail, restaurant, media innovation and consulting industries.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Harvard Business Review

AUGUST 3, 2016

That can benefit consumers through lower prices, more innovation, and better products. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. Research has shown that pharma mergers reduce innovation. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

The Horizons Tracker

FEBRUARY 22, 2022

billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. It’s a market that is already worth $3.1 “With 5G, you get fast upload speeds, up to 100Gbsp on many public networks.

Stephenson 91

Stephenson Wireless Christensen Automotive 91

Harvard Business Review

JULY 8, 2016

China has not been a huge technology innovator, despite being the world’s second-largest investor in R&D , but Chinese businesses have found ways to use innovations in processes, business models, and customer experience to their disruptive advantage. This presents Western companies with a fresh challenge.

Business Model 10

Business Model Innovation Company Apparel 10

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Strategy Driven

NOVEMBER 29, 2016

Always at the forefront of innovation, technologies pioneered by the military are often adopted by the commercial sector; companies looking for cyber knowledge or network engineering skills can find this expertise among veterans. Bill Sebra is Chief Operations Executive at Korn Ferry Futurestep. About the Author.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Strategy Driven

JUNE 22, 2018

When your operational and back office processes are aligned you work efficiently and productively. With life expectancy typically increasing and medical innovations positively impacting people’s health, for the first time since records began there are more seniors than children under 5 years. Your processes are A1.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Harvard Business Review

FEBRUARY 16, 2017

The same is true for social innovators. However, unlike many business leaders, it is easy for social innovators to overlook making an intentional effort to drive demand because the need for their innovation is so great. But even the most needed innovation does not sell itself. Consider that 86 million U.S.

Innovation 9

Innovation Rogers NGO Participative 9

Strategy Driven

JULY 13, 2011

Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth. Pharmaceutical companies have long needed deep scientific-innovation leadership capabilities but relatively few general managers.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors. Polycentric innovation won't work in organizations that promote groupthink. Cambridge, U.K. and the U.K.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Lack of consensus among players in a complex system is one of the biggest barriers to innovation. It's a classic change management problem.

Health Care 15

Health Care Innovation Pharmaceuticals Consensus 15

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 12

Innovation Company Biotechnology CFO 12

Harvard Business Review

JUNE 13, 2016

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain. And what can we learn from it? Commercial.

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. Profits are up. Corporate valuations are up as well.

Pharmaceuticals 11

Pharmaceuticals Politics Price Chemicals 11

Harvard Business Review

AUGUST 14, 2018

ineffective innovation strategies. failure to fully embed operations in China. 5 Principles for Innovation in Emerging Markets. Uber sold its operation to Didi Chuxing. Specific factors identified included: failure to cope with a very large number of local competitors. “It’s death by a thousand cuts!”

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

OCTOBER 26, 2017

“He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. As with many clusters, a university sits at its center: founded in AD 1088, the Studium of Bologna was the major educational innovation of Europe’s second millennium. How did the city make the leap?

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

OCTOBER 6, 2016

Right now, for example, the hot topic is “digital leadership” — driving organizations to be more innovative, iterative, and collaborative as they develop digital strategies to disrupt or transform their current business. The culture at GE, for example, centers on execution, simplicity, and innovation.

Leadership Pipeline 13

Leadership Pipeline Leadership After Action Review Pharmaceuticals 13

Harvard Business Review

MAY 20, 2014

In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others.

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Harvard Business Review

FEBRUARY 29, 2016

For example, it increased both the number and status of safety personnel, and it strengthened safety operating procedures. We then tested the model using quantitative data about the incidence of safety-related errors in the context of pharmaceutical drugs. But learning waned as avoiding launch delays became increasingly important.

Organization 8

Organization McCombs Pharmaceuticals Learning-by-Doing 8

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long. The options are tangible.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

JUNE 20, 2017

For organizations seeking to become more adaptive and innovative, culture change is often the most challenging part of the transformation. Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. Innovators developing new drugs, devices, and procedures should look beyond profits alone and incorporate the need to add value into their investments.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

JUNE 27, 2012

Paul is an old friend who, until his recent retirement, worked as a senior scientist at a pharmaceutical company, where he managed a group of innovative researchers. Some good scientists left the company, and others lost their innovative spark. If this homogenization had worked, it might well have spelled disaster.

COO 11

COO Short-term Pharmaceuticals Innovation 11

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. At the moment Apple can get away with this behavior, because it so powerful in the niche markets in which it operates and it has a small array of products. What's up with that?

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

JANUARY 24, 2012

I'll be joined by five CEOs, among them George Halvorson , who heads the health care provider Kaiser Permanente, Vincent Forlenza who runs Becton Dickinson, the pharmaceutical company, and Tim Brown , the CEO of IDEO, the design and innovation firm.

Meyer 14

Meyer Goleman Emotional Intelligence Pharmaceuticals 14

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Innovation, customization, speed, and location are also among the opportunities it offers. How could digital printing improve your innovation, product development, and speed to market? Threat analysis.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

JANUARY 8, 2013

Breaking down functional silos is key to everything from encouraging communication to building valuable connections to sparking innovation. arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). But, as we all know, bridging interdepartmental chasms is far easier said than done.

Company 9

Company Pharmaceuticals Health Care Participative 9

Harvard Business Review

OCTOBER 25, 2018

The superstars tend to be more involved in global flows of trade and finance, more digitally mature, and they dominate the lists of the most valued companies, the most valued brands, the most desirable places to work, and the most innovative companies. The link between superstar firms, sectors, and cities is complex.

Industry 13

Industry Company GDP Bottom-up 13